^
Association details:
| Biomarker: | HER-2 positive |
|---|---|
| Cancer: | Esophageal Adenocarcinoma |
| Drug: | carboplatin (Tubulin polymerization promoter) |
| Direction: | Resistant |
Evidence:
Source:
Title:
HER2-overexpression/amplification and survival in patients with resectable esophageal/gastroesophageal junction adenocarcinoma (E/GEJ-AC) treated with neoadjuvant carboplatin/paclitaxel-based chemoradiation
Published date:
01/11/2021
Excerpt:
After a median follow up of 23 mo, DFS and TTR were significantly shorter in HER2 positive (vs negative) pts...
DOI:
10.1200/JCO.2021.39.3_suppl.239
